Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs

Table 2 Baseline patient’s and procedural characteristics

	AIDA 2017		ABSORB III 2017		ABSORB China 2016		ABSORB II 2016		ABSORB Japan 2016
	BRS	EES	BRS	EES	BRS	EES	BRS	EES	BRS	EES
N of patients, n	924	921	1322	686	238	237	335	166	266	134
Age, yrs.	64	64	63	64	57	58	62	61	67	67
Male, %	72	76	71	70	72	73	76	80	79	74
Hypertension, %	51	50	85	85	59	60	69	72	78	80
Diabetes, %	18	17	31	33	25	23	24	24	36	36
Dyslipidaemia, %	38	38	86	86	42	38	75	80	82	82
Prior MI, %	18	19	21	22	17	16	28	28	16	24
STEMI, %	25		0		0		0		0
NSTEMI, %	20		0		0		0		0
UA, %	8		26		64		21		12
SA, %	40		58		19		64		64
Silent Ischaemia, %	NR		10		5		12		23
Intracoronary imaging, %	NR		100	100	0.4	0.4	100	100	100	100
Pre-dilation, %	97	91	100	100	99.6	98	100	99	100	100
Post dilation, %	74	49.1	65.5	51.2	63	54.4	61	59	82.2	77.4

yrs years, MI myocardial infarction BRS = bioresorbable vascular scaffold, EESeverolimus-eluting stent, STEMI ST-elevation myocardial infarction, NSTEMI No ST-elevation myocardial infarction;UA = unstable angina, SA stable angina, NR not reported

ISSN: 1471-2261